The WACC of Biomarin Pharmaceutical Inc (BMRN) is 7.5%.
| Range | Selected | |
| Cost of equity | 6.90% - 8.80% | 7.85% |
| Tax rate | 10.60% - 36.60% | 23.60% |
| Cost of debt | 4.00% - 4.50% | 4.25% |
| WACC | 6.6% - 8.3% | 7.5% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.65 | 0.71 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 6.90% | 8.80% |
| Tax rate | 10.60% | 36.60% |
| Debt/Equity ratio | 0.09 | 0.09 |
| Cost of debt | 4.00% | 4.50% |
| After-tax WACC | 6.6% | 8.3% |
| Selected WACC | 7.5% | |